688075 安旭生物
已收盘 05-15 15:00:01
资讯
新帖
简况
每周股票复盘:安旭生物(688075)已回购300,759股
证券之星 · 05-10
每周股票复盘:安旭生物(688075)已回购300,759股
安旭生物(688075)披露股份回购进展公告,5月6日股价下跌1.15%
证券之星 · 05-06
安旭生物(688075)披露股份回购进展公告,5月6日股价下跌1.15%
安旭生物(688075)2026年一季报简析:净利润同比下降130.44%,三费占比上升明显
证券之星 · 05-01
安旭生物(688075)2026年一季报简析:净利润同比下降130.44%,三费占比上升明显
股市必读:安旭生物一季报 - 第一季度单季净利润同比下降130.44%
证券之星 · 04-30
股市必读:安旭生物一季报 - 第一季度单季净利润同比下降130.44%
每周股票复盘:安旭生物(688075)首次回购8000股
证券之星 · 04-19
每周股票复盘:安旭生物(688075)首次回购8000股
安旭生物新注册《安旭生物实时温控孵育箱系统V1.0.0.10》项目的软件著作权
证券之星 · 04-19
安旭生物新注册《安旭生物实时温控孵育箱系统V1.0.0.10》项目的软件著作权
安旭生物(688075)披露以集中竞价交易方式首次回购公司股份公告,4月16日股价下跌0.33%
证券之星 · 04-16
安旭生物(688075)披露以集中竞价交易方式首次回购公司股份公告,4月16日股价下跌0.33%
每周股票复盘:安旭生物(688075)拟回购2500万至4900万元股份
证券之星 · 04-05
每周股票复盘:安旭生物(688075)拟回购2500万至4900万元股份
安旭生物(688075)披露以集中竞价交易方式回购股份方案,4月3日股价下跌1.41%
证券之星 · 04-03
安旭生物(688075)披露以集中竞价交易方式回购股份方案,4月3日股价下跌1.41%
安旭生物(688075.SH)拟2500万元至4900万元回购股份
智通财经 · 03-31
安旭生物(688075.SH)拟2500万元至4900万元回购股份
安旭生物新注册《自动切割机系统V1.0》项目的软件著作权
证券之星 · 03-27
安旭生物新注册《自动切割机系统V1.0》项目的软件著作权
安旭生物(688075)披露股东减持股份结果公告,3月3日股价下跌0.26%
证券之星 · 03-03
安旭生物(688075)披露股东减持股份结果公告,3月3日股价下跌0.26%
安旭生物(688075.SH)发预减,预计2025年年度归母净利润同比减少55.80%到63.08%
智通财经 · 01-30
安旭生物(688075.SH)发预减,预计2025年年度归母净利润同比减少55.80%到63.08%
1月26日安旭生物涨5.00%,鑫元专精特新混合A基金重仓该股
证券之星 · 01-26
1月26日安旭生物涨5.00%,鑫元专精特新混合A基金重仓该股
每周股票复盘:安旭生物(688075)股东马华祥减持80.45万股
证券之星 · 01-25
每周股票复盘:安旭生物(688075)股东马华祥减持80.45万股
1月22日安旭生物发布公告,股东减持80.45万股
证券之星 · 01-22
1月22日安旭生物发布公告,股东减持80.45万股
每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份
证券之星 · 2025-11-23
每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份
安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份
智通财经 · 2025-11-18
安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份
安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%
证券之星 · 2025-11-17
安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%
安旭生物获得外观设计专利授权:“凝血检验盘片”
证券之星 · 2025-03-11
安旭生物获得外观设计专利授权:“凝血检验盘片”
加载更多
公司概况
公司名称:
杭州安旭生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-11-18
主营业务:
杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是毒品检测、传染病检测、慢性病检测、妊娠检测、肿瘤检测、心肌检测、生化检测、过敏原检测。公司是国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心,荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。
发行价格:
78.28
{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":36.46,"timestamp":1778828401000,"preClose":37.48,"halted":0,"volume":633159,"delay":0,"changeRate":-0.0272,"floatShares":127000000,"shares":127000000,"eps":0.197,"marketStatus":"已收盘","change":-1.02,"latestTime":"05-15 15:00:01","open":37.43,"high":37.51,"low":36.2,"amount":23374400,"amplitude":0.035,"askPrice":36.47,"askSize":107,"bidPrice":36.46,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":37.48,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":41.23,"lowLimit":33.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":127082805,"isCdr":false,"pbRate":0.9,"roa":"--","peRate":185.076142,"roe":"--","epsLYR":0.55,"committee":-0.845758,"marketValue":4633000000,"turnoverRate":0.005,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-05-18。","afterMarket":{"amount":0,"volume":0,"close":36.46,"buyVolume":0,"sellVolume":0,"time":1778830437559,"indexStatus":"已收盘 05-15 15:30:00","preClose":37.48},"floatMarketCap":4633000000},"requestUrl":"/m/hq/s/688075/","defaultTab":"news","newsList":[{"id":"2634414022","title":"每周股票复盘:安旭生物(688075)已回购300,759股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634414022","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634414022?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:04","pubTimestamp":1778353452,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,安旭生物报收于37.3元,较上周的37.42元下跌0.32%。本周,安旭生物5月8日盘中最高价报37.75元。本周关注点公司公告汇总:安旭生物已累计回购300,759股,占总股本0.2367%。截至2026年4月30日,已累计回购300,759股,占总股本0.2367%,回购均价区间为37.51元/股至38.87元/股,支付资金总额1,148.25万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633518101","title":"安旭生物(688075)披露股份回购进展公告,5月6日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633518101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633518101?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:45","pubTimestamp":1778064318,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘,安旭生物报收于36.99元,较前一交易日下跌1.15%,最新总市值为47.01亿元。该股当日开盘37.71元,最高37.71元,最低36.98元,成交额达2171.94万元,换手率为0.46%。近日,安旭生物发布《关于股份回购进展公告》。公告显示,公司于2026年3月30日召开董事会,审议通过以集中竞价交易方式回购股份的方案,拟用于员工持股计划或股权激励。本次回购进展符合相关规定及方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660446","title":"安旭生物(688075)2026年一季报简析:净利润同比下降130.44%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660446","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660446?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:46","pubTimestamp":1777589164,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期安旭生物发布2026年一季报。截至本报告期末,公司营业总收入7119.89万元,同比下降38.25%,归母净利润-1036.0万元,同比下降130.44%。本报告期安旭生物三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达250.01%。然而去年的净利率为15.34%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631815520","title":"股市必读:安旭生物一季报 - 第一季度单季净利润同比下降130.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631815520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631815520?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:16","pubTimestamp":1777501008,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,安旭生物报收于37.58元,上涨0.48%,换手率0.35%,成交量4460.0手,成交额1679.57万元。来自业绩披露要点:安旭生物2026年一季度归母净利润为-1036.0万元,同比下降130.44%。业绩披露要点财务报告安旭生物2026年一季报显示,一季度公司主营收入7119.89万元,同比下降38.25%;归母净利润-1036.0万元,同比下降130.44%;扣非净利润-2038.39万元,同比下降189.56%;负债率10.62%,投资收益2329.9万元,财务费用3851.45万元,毛利率40.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000019565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628683751","title":"每周股票复盘:安旭生物(688075)首次回购8000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628683751","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628683751?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:37","pubTimestamp":1776541027,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,安旭生物报收于38.51元,较上周的38.7元下跌0.49%。本周,安旭生物4月15日盘中最高价报39.3元。安旭生物当前最新总市值48.94亿元,在医疗器械板块市值排名75/129,在两市A股市值排名3532/5198。本周关注点公司公告汇总:安旭生物于2026年4月16日首次回购股份8,000股,占总股本0.0063%。本次回购资金总额预计为2,500万元至4,900万元,回购股份将用于员工持股计划或股权激励。回购期限为2026年4月1日至2027年3月29日。本次回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628151756","title":"安旭生物新注册《安旭生物实时温控孵育箱系统V1.0.0.10》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628151756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628151756?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:48","pubTimestamp":1776534491,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物新注册了《安旭生物实时温控孵育箱系统V1.0.0.10》项目的软件著作权。今年以来安旭生物新注册软件著作权2个,较去年同期减少了75%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了4741万元,同比减4.56%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目150次;财产线索方面有商标信息76条,专利信息286条,著作权信息58条;此外企业还拥有行政许可110个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","159180","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296759","title":"安旭生物(688075)披露以集中竞价交易方式首次回购公司股份公告,4月16日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296759?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:52","pubTimestamp":1776333142,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,安旭生物报收于38.88元,较前一交易日下跌0.33%,最新总市值为49.41亿元。该股当日开盘39.2元,最高39.2元,最低38.69元,成交额达1059.73万元,换手率为0.21%。近日,安旭生物发布《关于以集中竞价交易方式首次回购公司股份的公告》。回购价格区间为38.86元/股至38.87元/股,已支付总金额310,938.39元。本次回购资金总额预计为2,500万元至4,900万元,回购股份将用于员工持股计划或股权激励。回购期限为2026年4月1日至2027年3月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625611597","title":"每周股票复盘:安旭生物(688075)拟回购2500万至4900万元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2625611597","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625611597?lang=zh_cn&edition=full","pubTime":"2026-04-05 04:03","pubTimestamp":1775332992,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,安旭生物报收于37.71元,较上周的37.04元上涨1.81%。本周关注点公司公告汇总:安旭生物拟以不低于2,500万元且不超过4,900万元自有资金回购股份,用于员工持股计划或股权激励。安旭生物关于以集中竞价交易方式回购股份的回购报告书杭州安旭生物科技股份有限公司于2026年3月30日召开董事会,审议通过以集中竞价交易方式回购股份的方案,回购资金总额不低于2,500万元且不超过4,900万元,资金来源为自有资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624565443","title":"安旭生物(688075)披露以集中竞价交易方式回购股份方案,4月3日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624565443","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624565443?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:55","pubTimestamp":1775213715,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,安旭生物报收于37.71元,较前一交易日下跌1.41%,最新总市值为47.92亿元。该股当日开盘38.24元,最高38.75元,最低37.51元,成交额达1889.33万元,换手率为0.39%。近日,安旭生物发布《关于以集中竞价交易方式回购股份方案的公告》。回购股份将用于员工持股计划或股权激励,实施期限为董事会审议通过之日起12个月内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300036127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623625300","title":"安旭生物(688075.SH)拟2500万元至4900万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2623625300","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623625300?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:04","pubTimestamp":1774951460,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安旭生物(688075.SH)发布公告,公司拟2500万元至4900万元回购股份,回购价格不超过41元/股(含),将用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893591","title":"安旭生物新注册《自动切割机系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622893591?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:30","pubTimestamp":1774549837,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物新注册了《自动切割机系统V1.0》项目的软件著作权。今年以来安旭生物新注册软件著作权1个,较去年同期减少了83.33%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了4741万元,同比减4.56%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目149次;财产线索方面有商标信息76条,专利信息271条,著作权信息57条;此外企业还拥有行政许可109个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616345354","title":"安旭生物(688075)披露股东减持股份结果公告,3月3日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616345354","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616345354?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:56","pubTimestamp":1772531763,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘,安旭生物报收于38.78元,较前一交易日下跌0.26%,最新总市值为49.28亿元。该股当日开盘38.87元,最高39.05元,最低38.51元,成交额达1880.48万元,换手率为0.38%。近日,安旭生物发布《股东减持股份结果公告》。公告显示,本次减持计划实施前,股东马华祥持有公司股份14,773,360股,占公司总股本的11.62%。本次减持计划已实施完毕,当前持股数量为13,573,360股,持股比例降至10.68%。本次减持符合相关法规及此前披露的减持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300032208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607046523","title":"安旭生物(688075.SH)发预减,预计2025年年度归母净利润同比减少55.80%到63.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046523","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607046523?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:47","pubTimestamp":1769780823,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 安旭生物(688075.SH)发布2025 年年度业绩预告,预计2025年年度实现归属于母公司所有者的净利润7100万元到8500万元,与上年同期(法定披露数据)相比,将减少10,729.53 万元到12,129.53万元,同比减少55.80%到63.08%。报告期内,公司主营业务保持稳健发展,为巩固在产业领域内的长期竞争优势,公司保持原有几大技术平台的先进性之外,持续加大对新技术平台的战略性投入,同时国内外市场及注册证书等拓展,海外分子公司的布局致使费用增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"安旭生物(688075.SH)发预减,预计2025年年度归母净利润同比减少55.80%到63.08%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606297382","title":"1月26日安旭生物涨5.00%,鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606297382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606297382?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:39","pubTimestamp":1769413149,"startTime":"0","endTime":"0","summary":"证券之星消息,1月26日安旭生物涨5.00%,收盘报42.84元,换手率2.92%,成交量3.72万手,成交额1.58亿元。1月26日的资金流向数据方面,主力资金净流入1288.71万元,占总成交额8.16%,游资资金净流出146.94万元,占总成交额0.93%,散户资金净流出1141.77万元,占总成交额7.23%。重仓安旭生物的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600014860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","399267","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606320932","title":"每周股票复盘:安旭生物(688075)股东马华祥减持80.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606320932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606320932?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:17","pubTimestamp":1769282230,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,安旭生物报收于40.8元,较上周的40.19元上涨1.52%。公司公告汇总安旭生物于2026年1月23日发布公告,持股5%以上股东马华祥在2026年1月6日至1月21日期间,通过集中竞价方式减持公司股份804,519股,持股比例由11.62%减少至10.99%,触及1%的整数倍变动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605612454","title":"1月22日安旭生物发布公告,股东减持80.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612454","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605612454?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:31","pubTimestamp":1769074306,"startTime":"0","endTime":"0","summary":"证券之星消息,1月22日安旭生物发布公告《安旭生物:安旭生物关于持股5%以上的股东权益变动触及1%刻度的提示性公告》,其股东马华祥于2026年1月6日至2026年1月21日间合计减持80.45万股,占公司目前总股本的0.6331%,变动期间该股股价上涨3.85%,截止1月21日收盘报41.05元。股东增减持详情见下表:根据安旭生物2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200028442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585105549","title":"每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105549?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:31","pubTimestamp":1763839873,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,安旭生物报收于38.85元,较上周的43.33元下跌10.34%。本周关注点股本股东变化:股东马华祥计划减持不超过公司总股本的0.94%。安旭生物股东减持股份计划公告杭州安旭生物科技股份有限公司股东马华祥持有公司股份14,773,360股,占总股本的11.62%,股份来源于首次公开发行前取得。因自身资金需求,马华祥计划通过集中竞价交易方式减持不超过1,200,000股,即不超过公司总股本的0.94%。本次减持计划与此前承诺一致,不存在导致公司控制权变更的风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584931860","title":"安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2584931860","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584931860?lang=zh_cn&edition=full","pubTime":"2025-11-18 19:24","pubTimestamp":1763465086,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安旭生物(688075.SH)发布公告,股东马华祥因自身资金需求,拟通过集中竞价交易方式减持其所持有的公司股份数量合计不超过120万股,即不超过公司总股本的0.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584253621","title":"安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584253621","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584253621?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:22","pubTimestamp":1763389321,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘,安旭生物报收于42.15元,较前一交易日下跌2.72%,最新总市值为53.57亿元。该股当日开盘43.33元,最高43.33元,最低41.85元,成交额达5499.81万元,换手率为1.02%。公司近日发布公告称,杭州安旭生物科技股份有限公司将于2025年11月25日14:00-15:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会,介绍公司2025年第三季度经营成果、财务状况,并回答投资者提问。投资者可于11月18日至11月24日16:00前通过上证路演中心或公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518202438","title":"安旭生物获得外观设计专利授权:“凝血检验盘片”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202438?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:14","pubTimestamp":1741634076,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权,专利名为“凝血检验盘片”,专利申请号为CN202430353581.1,授权日为2025年3月11日。今年以来安旭生物新获得专利授权4个,较去年同期减少了42.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100003347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778937753759,"stockEarnings":[{"period":"1week","weight":-0.0225},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0716},{"period":"6month","weight":-0.1586},{"period":"1year","weight":0.0272},{"period":"ytd","weight":-0.0572}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5761人(较上一季度增加2.44%)","perCapita":"22059股","listingDate":"2021-11-18","address":"浙江省杭州市余杭区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":" 杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是毒品检测、传染病检测、慢性病检测、妊娠检测、肿瘤检测、心肌检测、生化检测、过敏原检测。公司是国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心,荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}